Korean J Hepatol.
1999 Jun;5(2):105-115.
Persistent Negative Anti-Bc in Chronic Hepatitis B Virus Carrier: linical Review,
HBcAg and Nucleotide Sequence of It's Epitope in HLA A2 Heterozygotes
Abstract
- BACKGROUND/AIMS
HBcAg is the most immunogenic HBV component and anti-Bc usually persists
irrespective of ongoing liver disease or clearance of the virus in human. Therefore anti-Bc
is considered as the most sensitive and occasionally the only marker of the HBV infection.
Nevertheless, there are a few HBsAg carrier with persistent negative anti-Bc.
The epitope which responds to HBcAg is recently defined in HLA A2 from acute viral hepatitis
patient due to HBV. So we studied the clinical and laboratory features and nucleotide sequence
of HBcAg corresponding to HLA A2 in the HBsAg carrier with persistent negative anti-Bc.
METHODS
The subject of these study consists of eight HBsAg chronic carriers with persistent
negative anti-Bc. We followed up the clinical features and serological markers of HBV infection
and determined the amount of humoral immunoglobulin, HBV DNA and HBcAg when we performed
the HLA class I typing and sequencing analysis of core of HBV. Control cases were selected
from 3 HLA A2 heterozygote cases with chronic HBsAg carriers with anti-Bc.
RESULTS
All subjects had the HBsAg persistently and good health conditions with normal
ranges of aminotransferase and humoral immunoglobulin. One of them was converted to
anti-Bc-ositive during follow-p period. The level of HBV DNA in serum was higher
than 1.2 pg/mL in 7 of 8 chronic HBV carriers. There was a trend of differences between
chronic anti-Bc negative carriers and converted one case to anti-Bc positive
in the serum of HBcAg and HBV DNA(p=0.06). But strong positive correlation was
observed between the amount of HBcAg and HBV DNA in sera. The core portion of HBV
was amplified in 4 of 6 HLA A2 heterozygotes by single PCR. When sequenced the PCR
products of the above 4 chronic anti-Bc negative HBV carriers and 3 control cases directly,
there were no significant difference in the nucleotide and amino acid sequence at the HBcAg
epitope which corresopond to class 1 HLA A2.
CONCLUSIONS
Our results show that persistent anti-Bc negative chronic HBV carriers may be
caused by large amounts of HBV DNA and HBcAg in their sera and not by variants of HBV.
These suggested that active viral replication was going on, but are undetectable
by the available commercial tests due to binding with excessive amount of HBcAg
in the HBV carriers with persistent negative anti-Bc.